E&Investment Inc. 13D and 13G filings for NeuroBo Pharmaceuticals, Inc.:
- Schedule 13D must be filed within ten days after a person or an organization acquires beneficial ownership of more than 5% of a voting class of a company's equity securities.
- Shares have been adjusted for stock splits.
| Reported DateTime | Transaction Date | Type | Company Symbol | Filed By Symbol | Shares Owned % Owned | Shares Vs. Prev Report | View |
| 2022-08-05 4:25 pm Sale | 2022-07-26 | 13D | NeuroBo Pharmaceuticals, Inc. NRBO | E&Investment Inc. | 25,474 22.900% | -5,033 (-16.50%) | Filing |
| 2021-08-30 10:27 am Unchanged | 2021-08-27 | 13D | NeuroBo Pharmaceuticals, Inc. NRBO | E&Investment Inc. | 30,507 32.900% | 0 (Unchanged) | Filing |
| 2021-03-15 06:05 am Unchanged | 2021-03-09 | 13D | NeuroBo Pharmaceuticals, Inc. NRBO | E&Investment Inc. | 30,507 33.000% | 0 (Unchanged) | Filing |